DataVXChemistry of MaterialsPaper
journal article·2026-05-26Open access

Galvanic Replacement Incorporation of Ultrasmall Gold–Silver Nanoparticles within a Titanium Aminoterephthalate Framework

Catalina Biglione, Sorraya N. K. Lelouche, Manuela Cedrun-Morales, Manuel Ceballos, C. B. Huesa-Carballo, Darina Francesca Picchi, Timothy Martin Craig, Sara Bals, Jorge Barbazan, Pablo del Pino, Patricia Horcajada

Chemistry of Materials· Volume 38· Issue 10
Publisher pageOpen full text
Source abstract

Abstract

(Ti). This approach enables controlled incorporation of alloy nanoparticles both at the external surface and within the internal porosity of the MOF while preserving the crystalline structure and colloidal stability of the host framework. Comprehensive structural and compositional characterization confirms the successful formation of confined Au/Ag alloy nanostructures. The functional implications of alloy confinement are illustrated through irradiation experiments, which indicate an enhanced interaction with ionizing radiation compared to the pristine MOF. These results highlight the potential of MOF-confined bimetallic alloys as a versatile platform for applications requiring controlled nanoscale composition, stability, and interactions.
Source: openalex_inverted_index · Quality: baseline

Research context

Metals & alloysNanomaterials

OpenAlex topics: Nanomaterials for catalytic reactions · Environmental remediation with nanomaterials · Copper Interconnects and Reliability

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Advanced Porous Materials Unit, IMDEA Energy Institute, Avda. Ramón de la Sagra, 3, Móstoles 28935 Madrid, Spain

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas

Universidade de Santiago de Compostela

University of Santiago de Compostela

Translational Medical Oncology Group (ONCOMET)

Health Research Institute of Santiago de Compostela (IDIS)

EMAT and NANOlab Center of Excellence, University of Antwerp, Groenenborgerlaan 171, Antwerp 2020, Belgium

Funding

Ministerio de Ciencia, Innovaci?n y Universidades · Fundaci?n Cient?fica Asociaci?n Espa?ola Contra el C?ncer · H2020 Marie Sklodowska-Curie Actions · HORIZON EUROPE Marie Sklodowska-Curie Actions · Universidade de Santiago de Compostela · Banco Santander

References (48)

Show source-provided references
1. 10.1016/j.cocis.2019.02.00410.1016/j.cocis.2019.02.004 ↗
2. 10.1021/acsnano.1c0150010.1021/acsnano.1c01500 ↗
3. 10.1021/acs.jpcc.9b0322010.1021/acs.jpcc.9b03220 ↗
4. 10.1016/j.ccr.2015.08.00210.1016/j.ccr.2015.08.002 ↗
5. 10.1039/C6MH00586A10.1039/C6MH00586A ↗
6. 10.1021/acsnanoscienceau.3c0004110.1021/acsnanoscienceau.3c00041 ↗
7. 10.1080/17425247.2022.213024510.1080/17425247.2022.2130245 ↗
8. 10.1016/j.scib.2018.03.00910.1016/j.scib.2018.03.009 ↗
9. 10.1016/j.apmt.2020.10056410.1016/j.apmt.2020.100564 ↗
10. 10.1002/adma.20130282010.1002/adma.201302820 ↗
11. 10.1021/acs.accounts.3c0006710.1021/acs.accounts.3c00067 ↗
12. 10.1021/acsami.8b1238010.1021/acsami.8b12380 ↗
13. 10.1002/slct.20170090810.1002/slct.201700908 ↗
14. 10.1016/j.talo.2025.10043310.1016/j.talo.2025.100433 ↗
15. 10.1002/asia.20160046910.1002/asia.201600469 ↗
16. 10.1021/acscentsci.8b0080510.1021/acscentsci.8b00805 ↗
17. 10.1021/ja109900610.1021/ja1099006 ↗
18. 10.1021/ja903726m10.1021/ja903726m ↗
19. 10.1039/D1TA02251B10.1039/D1TA02251B ↗
20. 10.1039/D2CC05851K10.1039/D2CC05851K ↗
21. 10.1021/acs.jpcc.0c0893910.1021/acs.jpcc.0c08939 ↗
22. 10.1016/j.ultramic.2020.11319110.1016/j.ultramic.2020.113191 ↗
23. 10.1364/OE.24.02512910.1364/OE.24.025129 ↗
24. 10.1016/j.ultramic.2015.05.00210.1016/j.ultramic.2015.05.002 ↗
25. 10.3390/nano710032110.3390/nano7100321 ↗
26. 10.1039/D3CS00793F10.1039/D3CS00793F ↗
27. 10.1016/j.ccr.2024.21630210.1016/j.ccr.2024.216302 ↗
28. 10.1126/science.123044410.1126/science.1230444 ↗
29. 10.1021/acsami.4c0310610.1021/acsami.4c03106 ↗
30. 10.1016/j.molstruc.2010.07.03310.1016/j.molstruc.2010.07.033 ↗
31. 10.1021/acsami.5b0830510.1021/acsami.5b08305 ↗
32. 10.1016/j.enconman.2016.09.01510.1016/j.enconman.2016.09.015 ↗
33. 10.1021/acs.jpcc.5b0511010.1021/acs.jpcc.5b05110 ↗
34. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
35. 10.31031/PSPRJ.2024.05.00061510.31031/PSPRJ.2024.05.000615 ↗
36. 10.1002/aic.1483910.1002/aic.14839 ↗
37. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
38. 10.1016/j.ijpharm.2025.12619610.1016/j.ijpharm.2025.126196 ↗
39. 10.1021/acsami.4c0617410.1021/acsami.4c06174 ↗
40. 10.1021/la501255510.1021/la5012555 ↗
41. 10.1021/ja057254a10.1021/ja057254a ↗
42. 10.1039/C4NR00708E10.1039/C4NR00708E ↗
43. 10.1021/acsabm.2c0001410.1021/acsabm.2c00014 ↗
44. 10.1002/adhm.20170150310.1002/adhm.201701503 ↗
45. 10.1016/j.nantod.2015.04.00210.1016/j.nantod.2015.04.002 ↗
46. 10.1021/acsnano.8b0922110.1021/acsnano.8b09221 ↗
47. 10.1021/acsnano.9b0985810.1021/acsnano.9b09858 ↗
48. 10.1016/j.biomaterials.2020.12064210.1016/j.biomaterials.2020.120642 ↗